Literature DB >> 21525907

The rise of people power.

Roger Chafe1, Karen B Born, Arthur S Slutsky, Andreas Laupacis.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21525907     DOI: 10.1038/472410a

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


× No keyword cloud information.
  6 in total

1.  Venous and cerebrospinal fluid flow in multiple sclerosis: a case-control study.

Authors:  Peter Sundström; Anders Wåhlin; Khalid Ambarki; Richard Birgander; Anders Eklund; Jan Malm
Journal:  Ann Neurol       Date:  2010-08       Impact factor: 10.422

2.  Multiple sclerosis: is multiple sclerosis caused by venous insufficiency?

Authors:  Richard A Rudick
Journal:  Nat Rev Neurol       Date:  2010-09       Impact factor: 42.937

3.  The whys of cancer quackery.

Authors:  I J Lerner
Journal:  Cancer       Date:  1984-02-01       Impact factor: 6.860

4.  No cerebrocervical venous congestion in patients with multiple sclerosis.

Authors:  Florian Doepp; Friedemann Paul; José M Valdueza; Klaus Schmierer; Stephan J Schreiber
Journal:  Ann Neurol       Date:  2010-08       Impact factor: 10.422

5.  A prospective open-label study of endovascular treatment of chronic cerebrospinal venous insufficiency.

Authors:  Paolo Zamboni; Roberto Galeotti; Erica Menegatti; Anna Maria Malagoni; Sergio Gianesini; Ilaria Bartolomei; Francesco Mascoli; Fabrizio Salvi
Journal:  J Vasc Surg       Date:  2009-12       Impact factor: 4.268

6.  Chronic cerebrospinal venous insufficiency in patients with multiple sclerosis.

Authors:  P Zamboni; R Galeotti; E Menegatti; A M Malagoni; G Tacconi; S Dall'Ara; I Bartolomei; F Salvi
Journal:  J Neurol Neurosurg Psychiatry       Date:  2008-12-05       Impact factor: 10.154

  6 in total
  24 in total

Review 1.  CCSVI and MS: a statement from the European Society of neurosonology and cerebral hemodynamics.

Authors:  Claudio Baracchini; José M Valdueza; Massimo Del Sette; Galina Baltgaile; Eva Bartels; Natan M Bornstein; Juergen Klingelhoefer; Carlos Molina; Kurt Niederkorn; Mario Siebler; Matthias Sturzenegger; Bernd E Ringelstein; David Russell; Laszlo Csiba
Journal:  J Neurol       Date:  2012-05-31       Impact factor: 4.849

Review 2.  Patient-important activity and participation outcomes in clinical trials involving children with chronic conditions.

Authors:  Nora Fayed; Olaf Kraus de Camargo; Inam Elahi; Ankita Dubey; Ricardo M Fernandes; Amy Houtrow; Eyal Cohen
Journal:  Qual Life Res       Date:  2013-09-13       Impact factor: 4.147

Review 3.  CCSVI and MS: no meaning, no fact.

Authors:  Claudio Baracchini; Matteo Atzori; Paolo Gallo
Journal:  Neurol Sci       Date:  2012-05-09       Impact factor: 3.307

4.  [Knowledge transfer between research and practice].

Authors:  C Stein
Journal:  Anaesthesist       Date:  2011-05       Impact factor: 1.041

5.  Democratizing clinical research.

Authors:  Keith Lloyd; Jo White
Journal:  Nature       Date:  2011-06-15       Impact factor: 49.962

6.  Too soon to translate?

Authors: 
Journal:  Nat Med       Date:  2011-07-07       Impact factor: 53.440

7.  Can Facebook influence funding?

Authors:  Paolo Zamboni
Journal:  Nature       Date:  2011-05-26       Impact factor: 49.962

Review 8.  Chronic cerebrospinal venous insufficiency and multiple sclerosis: a comprehensive meta-analysis of case-control studies.

Authors:  Georgios Tsivgoulis; Theodoros N Sergentanis; Andrew Chan; Konstantinos Voumvourakis; Nikos Triantafyllou; Theodora Psaltopoulou; Ralf Gold; Christos Krogias
Journal:  Ther Adv Neurol Disord       Date:  2014-03       Impact factor: 6.570

9.  Social Media Representation of Chronic Cerebrospinal Venous Insufficiency Intervention for Multiple Sclerosis.

Authors:  Setareh Ghahari; Susan J Forwell
Journal:  Int J MS Care       Date:  2016 Mar-Apr

Review 10.  Reflections on translation: Views of participants in a multisite Canadian CCSVI clinical trial.

Authors:  Shelly Benjaminy; Cody Lo; Judy Illes; Anthony Traboulsee
Journal:  Neurol Clin Pract       Date:  2018-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.